Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EHC
EHC logo

EHC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
106.920
Open
105.200
VWAP
105.97
Vol
854.55K
Mkt Cap
10.50B
Low
105.135
Amount
90.56M
EV/EBITDA(TTM)
--
Total Shares
99.20M
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
Show More

Events Timeline

(ET)
2026-05-29
08:40:00
Encompass Health to Build 36-Bed Rehab Hospital in West Virginia
select
2026-05-11 (ET)
2026-05-11
16:40:00
Encompass Health to Build 50-Bed Rehab Hospital in Idaho
select
2026-03-18 (ET)
2026-03-18
16:50:00
Encompass Health to Build 40-Bed Rehabilitation Hospital in Delaware
select
2026-02-13 (ET)
2026-02-13
08:10:00
Encompass Health to Build 50-Bed Rehab Hospital in Mississippi
select
2026-02-12 (ET)
2026-02-12
09:30:00
Enhabit and Encompass Health Awarded $43.1M
select
2026-02-05 (ET)
2026-02-05
20:00:00
Amazon Falls Over 10% After Earnings Report
select

News

Newsfilter
8.5
05-29Newsfilter
PinnedEncompass Health to Build New Rehabilitation Hospital in West Virginia
  • New Hospital Announcement: Encompass Health has announced plans to build a 36-bed freestanding rehabilitation hospital in Bridgeport, West Virginia, which will expand its former 19-bed unit to meet the growing rehabilitation care needs in the area.
  • Facility and Service Enhancements: The new hospital will feature all private patient rooms, a state-of-the-art therapy gym, an activities of daily living suite, and an in-house dialysis suite, aiming to improve patient quality of life and functional recovery through comprehensive physical, occupational, and speech therapies.
  • Expanded Patient Services: The hospital will focus on patients recovering from conditions such as stroke, neurological disorders, brain and spinal cord injuries, and complex orthopedic issues, providing 24-hour nursing care and specialized services from an interdisciplinary team to enhance recovery outcomes.
  • Temporary Service Arrangements: During the construction of the new hospital, Encompass Health's Morgantown rehabilitation hospital has temporarily expanded its capacity to ensure continuity of care for patients, demonstrating the company's commitment to patient services.
PRnewswire
8.5
05-29PRnewswire
Encompass Health to Build New Rehabilitation Hospital in West Virginia
  • New Hospital Announcement: Encompass Health has announced plans to construct a freestanding 36-bed rehabilitation hospital in Bridgeport, West Virginia, aimed at expanding access to rehabilitation care for local patients in response to increasing demand in the area.
  • Facility Enhancements: The new hospital will feature all private patient rooms, a state-of-the-art therapy gym, and an activities of daily living suite, which is expected to significantly enhance patient rehabilitation experiences and quality of life.
  • Expanded Service Offerings: The hospital will provide 24-hour nursing care and physical, occupational, and speech therapies for patients recovering from strokes, neurological conditions, and spinal cord injuries, thereby strengthening Encompass Health's competitive position in the rehabilitation market.
  • Temporary Care Arrangements: During the construction of the new hospital, Encompass Health's Morgantown rehabilitation hospital has temporarily expanded its capacity to ensure continuity of care for patients, demonstrating the company's commitment to patient service.
NASDAQ.COM
7.0
05-25NASDAQ.COM
BrightSpring Health Services Raises 2026 Outlook Following Strong Q1 Performance
  • Revenue Outlook Raised: BrightSpring has increased its 2026 revenue forecast to $14.725 billion to $15.225 billion, up from the previous range of $14.450 billion to $15.00 billion, indicating strong confidence in future growth, particularly in pharmacy and provider services.
  • Profitability Improvement: The adjusted EBITDA range has been lifted to $795 million to $825 million, reflecting management's confidence in margin expansion, which is expected to offset revenue pressures from policy changes through efficiency gains and business integration.
  • Strong Q1 Performance: BrightSpring reported adjusted earnings per share of 39 cents in the first quarter, exceeding the market expectation of 29 cents and more than doubling year-over-year, showcasing significant improvements in profitability and market competitiveness.
  • Healthy Cash Flow Position: By the end of the first quarter, BrightSpring had $888.8 million in cash and cash equivalents, a substantial increase from $88.4 million in the prior quarter, indicating improved financial flexibility that supports future debt reduction and selective reinvestment.
seekingalpha
8.5
05-14seekingalpha
Encompass Health Prices $500M Senior Notes Offering at 5.875%
  • Financing Size: Encompass Health successfully priced a $500M offering of 5.875% senior notes, priced at 100% of principal value and maturing in 2034, demonstrating strong capital market access.
  • Interest Payment Structure: Interest on the notes will be paid semiannually on June 1 and December 1, with the first payment scheduled for December 1, 2026, ensuring stable future cash flows and boosting investor confidence.
  • Use of Proceeds: Proceeds will be used to redeem $400M of 4.500% senior notes and repay $100M under the senior secured revolving credit facility, optimizing the capital structure and reducing financial costs.
  • Strategic Outlook: Encompass Health raised its 2026 revenue outlook to $6.375B-$6.470B while planning to open seven new hospitals, indicating a proactive strategic approach to business expansion and market share enhancement.
PRnewswire
2.0
05-14PRnewswire
Encompass Health Announces Redemption of 4.5% Senior Notes
  • Debt Redemption Announcement: Encompass Health has announced the redemption of $400 million of its 4.5% senior notes due 2028, with the redemption price set at 100% of par plus accrued interest, expected to be paid on June 15, 2026.
  • Financial Impact: The company anticipates recording an approximate $3.2 million loss on early extinguishment of debt in Q2 2026, which will negatively affect its short-term financial performance.
  • Bond Balance Status: As of May 14, 2026, the total outstanding amount of the 2028 senior notes was $800 million, and this redemption will reduce the company's debt burden, despite incurring a loss in the short term.
  • Company Background: Encompass Health is the largest operator of inpatient rehabilitation hospitals in the U.S., with 175 facilities providing high-quality rehabilitative care, and despite facing financial challenges, it is recognized as America's Most Awarded Leader in Inpatient Rehabilitation.
seekingalpha
8.5
05-14seekingalpha
Encompass Health Launches $500M Senior Notes Offering
  • Bond Offering Initiative: Encompass Health (EHC) has commenced a private offering of $500 million in senior notes due 2034, reflecting the company's proactive financing strategy in the capital markets.
  • Guarantee Structure: The notes will be guaranteed on a senior unsecured basis by the company's subsidiaries, which also guarantee its credit agreement and other capital market debts, enhancing the credit rating of the bonds.
  • Use of Proceeds: EHC plans to use the proceeds along with available cash to redeem $400 million of its outstanding 4.500% senior notes due 2028 at par, aiming to reduce interest burdens and optimize its capital structure.
  • Credit Facility Repayment: Part of the proceeds will also be allocated to repay $100 million outstanding under its senior secured revolving credit facility, further improving the company's liquidity and financial flexibility.
Wall Street analysts forecast EHC stock price to rise
5 Analyst Rating
Wall Street analysts forecast EHC stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
134.00
Averages
146.75
High
160.00
Current: 0.000
sliders
Low
134.00
Averages
146.75
High
160.00
TD Cowen
NULL
to
Buy
initiated
$125
AI Analysis
2026-05-28
New
Reason
TD Cowen
Price Target
$125
AI Analysis
2026-05-28
New
initiated
NULL
to
Buy
Reason
TD Cowen initiated coverage of Encompass Health with a Buy rating and $125 price target. The firm says that in an under-supplied inpatient rehab industry, Encompass is "successfully executing a multipronged growth strategy" to fill demand while funding growth and buybacks with its cash flow. Raising leverage on the balance sheet "nominally" to 2.5-times and investing in further growth will drive annual EBITDA upside by 2030 versus the company's long-term algorithm, the analyst tells investors in a research note.
Barclays
NULL -> Overweight
maintain
$153 -> $140
2026-05-05
Reason
Barclays
Price Target
$153 -> $140
2026-05-05
maintain
NULL -> Overweight
Reason
Barclays lowered the firm's price target on Encompass Health to $140 from $153 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q1 report. High occupancy rates may constrain Encompass' volume growth near-term, but there is evidence of further opportunity to meet demand with de novo development, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EHC
Unlock Now

Valuation Metrics

The current forward P/E ratio for Encompass Health Corp (EHC.N) is 17.06, compared to its 5-year average forward P/E of 19.23. For a more detailed relative valuation and DCF analysis to assess Encompass Health Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
19.23
Current PE
17.06
Overvalued PE
21.31
Undervalued PE
17.16

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.75
Current EV/EBITDA
7.85
Overvalued EV/EBITDA
11.91
Undervalued EV/EBITDA
9.60

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.49
Current PS
1.51
Overvalued PS
1.73
Undervalued PS
1.24

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what other stocks should I buy and why
Intellectia · 14 candidates
Market Cap: >= 10.00BAnalyst Consensus: Strong Buy, Moderate BuyEps 5yr Cagr: >= 10Pe Ttm: 10 - 35Target Price Upside Potential: MoreAbovePriceOne Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
PTC logo
PTC
PTC Inc
19.39B
MSFT logo
MSFT
Microsoft Corp
3.01T
NVO logo
NVO
Novo Nordisk A/S
171.90B
SEIC logo
SEIC
SEI Investments Co
10.00B
BMRN logo
BMRN
BioMarin Pharmaceutical Inc
11.62B
BR logo
BR
Broadridge Financial Solutions Inc
22.04B
what are the best stocks to buy today
Intellectia · 16 candidates
Market Cap: >= 10.00BRegion: USAnalyst Consensus: Strong Buy, Moderate BuyList Exchange: XNYS, XNAS, XASETarget Price Upside Potential: MoreAbovePriceMoving Average Relationship: PriceAboveMA20
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.65T
PDD logo
PDD
PDD Holdings Inc
150.14B
QCOM logo
QCOM
Qualcomm Inc
149.82B
SMFG logo
SMFG
Sumitomo Mitsui Financial Group, Inc
148.10B
SNY logo
SNY
Sanofi SA
114.04B
CEG logo
CEG
Constellation Energy Corp
106.46B
what stock to buy Monday
Intellectia · 5 candidates
Market Cap: >= 10.00BBeta: LowRisk, ModerateRiskWeekly Average Turnover: >= 1,000,000Rsi 14: <= 35Week Price Change Pct: >= $-1.00
Ticker
Name
Market Cap$
top bottom
ET logo
ET
Energy Transfer LP
60.60B
MPLX logo
MPLX
MPLX LP
56.57B
PAA logo
PAA
Plains All American Pipeline LP
13.48B
YMM logo
YMM
Full Truck Alliance Co Ltd
10.30B
EHC logo
EHC
Encompass Health Corp
10.00B
find similar stocks of hims and hers
Intellectia · 208 candidates
Market Cap: 300.00M - 15.00BPs Ratio: <= 15.00Is Optionable: TrueAnnual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
GH logo
GH
Guardant Health Inc
14.98B
ICLR logo
ICLR
ICON PLC
14.12B
PEN logo
PEN
Penumbra Inc
14.03B
SOLV logo
SOLV
Solventum Corp
13.94B
SNN logo
SNN
Smith & Nephew PLC
13.91B
NBIX logo
NBIX
Neurocrine Biosciences Inc
13.50B
share the top 100 instead of 12
Intellectia · 24 candidates
Market Cap: >= 1000.00MNet Margin: >= 10.00Weekly Average Turnover: >= 1,000,000Pe Ttm: 17 - 23Return On Equity: >= 18.0%Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
NVS logo
NVS
Novartis AG
278.44B
COIN logo
COIN
Coinbase Global Inc
61.19B
AU logo
AU
Anglogold Ashanti PLC
51.18B
KGC logo
KGC
Kinross Gold Corp
43.05B
FUTU logo
FUTU
Futu Holdings Ltd
23.11B
FTI logo
FTI
TechnipFMC PLC
21.93B

Whales Holding EHC

O
Oberweis Asset Management, Inc.
Holding
EHC
+33.52%
3M Return
S
Systematic Financial Management LP
Holding
EHC
+15.87%
3M Return
R
Reinhart Partners, LLC
Holding
EHC
+14.62%
3M Return
T
Trillium Asset Management, LLC
Holding
EHC
+11.58%
3M Return
F
Fuller & Thaler Asset Management, Inc.
Holding
EHC
+4.82%
3M Return
S
Scout Investments, Inc.
Holding
EHC
+1.53%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Encompass Health Corp (EHC) stock price today?

The current price of EHC is 105.85 USD — it has increased 0.47

What is Encompass Health Corp (EHC)'s business?

Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.

What is the price predicton of EHC Stock?

Wall Street analysts forecast EHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EHC is146.75 USD with a low forecast of 134.00 USD and a high forecast of 160.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Encompass Health Corp (EHC)'s revenue for the last quarter?

Encompass Health Corp revenue for the last quarter amounts to 1.59B USD, increased 9.01

What is Encompass Health Corp (EHC)'s earnings per share (EPS) for the last quarter?

Encompass Health Corp. EPS for the last quarter amounts to 1.93 USD, increased 30.41

How many employees does Encompass Health Corp (EHC). have?

Encompass Health Corp (EHC) has 24611 emplpoyees as of May 31 2026.

What is Encompass Health Corp (EHC) market cap?

Today EHC has the market capitalization of 10.50B USD.